about
Environmental influences on familial discordance of phenotype in people with homocystinuria: a case reportIncreased plasma fibrinolysis and tissue-type plasminogen activator/tissue-type plasminogen activator inhibitor ratios after ethanol withdrawal in chronic alcoholics.[Ecchymosis as the presenting manifestation of Wilson disease: A case report].Psychiatric adult-onset of urea cycle disorders: A case-series.Iron metabolism disturbance in a French cohort of ALS patientsA pilot longitudinal study of the use of waxy maize heat modified starch in the treatment of adults with glycogen storage disease type I: a randomized double-blind cross-over study.Adult onset ornithine transcarbamylase deficiency: an unusual cause of semantic disorders.A practical approach to maternal phenylketonuria management.Genotype-phenotype associations in French patients with phenylketonuria and importance of genotype for full assessment of tetrahydrobiopterin responsivenessGuidelines for the diagnosis and management of cystathionine beta-synthase deficiency.Fabry disease 'The New Great Imposter': results of the French Observatoire in Internal Medicine Departments (FIMeD).Reduced cardiolipin content decreases respiratory chain capacities and increases ATP synthesis yield in the human HepaRG cells.Regulation of hepatic cardiolipin metabolism by TNFα: Implication in cancer cachexia.Comparison of idiopathic (isolated) aortitis and giant cell arteritis-related aortitis. A French retrospective multicenter study of 117 patients.Key European guidelines for the diagnosis and management of patients with phenylketonuria.18 FDG PET/CT contribution in occult giant-cell arteritis.[Cutaneous ulcers and glycogen storage disease type 1b].Posterior reversible encephalopathy syndrome and systemic vasculitis: report of six cases.[Retroperitoneal fibrosis in adults: Main characteristics and relevance of the diagnostic procedures based on a retrospective multicenter study on 77 cases].Vitamin D is Not a Protective Factor in ALS.Primary Sjögren's syndrome and occupational risk factors: A case-control study.A Multiplatform Metabolomics Approach to Characterize Plasma Levels of Phenylalanine and Tyrosine in Phenylketonuria.The complete European guidelines on phenylketonuria: diagnosis and treatment.Rituximab for Sjögren syndrome-associated type II mixed cryoglobulinemic cerebral vasculitis.Is epidural lipomatosis associated with abnormality of body fat distribution? A case report.Multidimensional analysis of clinical symptoms in patients with Fabry's disease.[Alcohol and nutrition]Nutritional assessment of amyotrophic lateral sclerosis in routine practice: value of weighing and bioelectrical impedance analysis."Big IGF-II"-induced hypoglycemia secondary to gastric adenocarcinoma.Hyperphenylalaninemia Correlated with Global Decrease of Antioxidant Genes Expression in White Blood Cells of Adult Patients with Phenylketonuria.Variability in creatinine excretion in adult diabetic, overweight men and women: consequences on creatinine-based classification of renal disease.[Dietary advice for treatment of inborn errors of metabolism in adult neurology: principes and limitations][Urea cycle disorders in adult patients]Issues with European guidelines for phenylketonuria - Authors' reply.Quality of life of patients treated for giant cell arteritis: a case-control study.Inborn Errors of Metabolism in Elderly Adults.Validation of amino-acids measurement in dried blood spot by FIA-MS/MS for PKU management.Liver involvement in urea cycle disorders: a review of the literature.Acute Lower Limb Ischaemia and Diabetes in a Patient Treated with Anti-PD1 Monoclonal Antibody for Metastatic Melanoma.Mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study.
P50
Q21202129-5045BE65-92E7-474A-BBDB-FC6A1A3E6147Q32068519-57453C43-6150-46E2-9BF8-862C8517320CQ33435414-E00E5F88-F625-4950-A77B-27EBEE586A2DQ33887237-9E61EAEC-5EBE-4AC1-81B2-003C554052AAQ33914518-F7F74317-3C58-44D7-93E5-8F0E725A6F99Q35121019-42CE10FE-04A2-454E-B795-298FAC64A8D3Q35481573-53554D78-3BD3-418D-A65F-46E291078AC6Q36757409-640BB724-5F5A-492F-9FDE-4EAAFFA31D83Q37259086-CF4C292C-25C1-4BD3-8DCC-FD2015207C3CQ37547501-2160538F-77F4-488C-8E2C-95B28219C726Q37881984-4A79172D-DC12-493B-82E3-7A0731AFF4D0Q38410643-7E6CDF92-F136-489A-BEC6-13BA0F933E00Q38412318-EC335FE4-8BA1-4BF0-B4A8-07E843E68DD0Q38745735-C25C3D03-22A6-41D1-B99D-57A32FA23DF6Q39084317-EBAD5640-5C07-4AD4-9D46-C8EB8F38BC31Q40296340-C7B60CA5-B2CB-4311-A27F-92D869AA8FB0Q40358578-4D9F126A-FE3E-492D-991B-D468343899BBQ40494356-3CC4E0F3-0B44-4D88-A017-A16C05E28D38Q41295132-FCA88817-6156-44FF-8C11-7A622329FE83Q41652246-98730368-E632-450C-A03D-229C58B2A8BBQ41745984-0C0593B4-CE31-4C1E-957E-65514A431C7BQ42148990-BF04BB04-4DEC-44C2-85D4-168C092464C0Q42376686-09D7B077-E077-4F4F-9B45-D459CE1FA8F4Q42413961-3BE5FEBC-CC98-4BEA-BB5D-D17CD64ED866Q42734656-C56261DC-608B-4CF6-860E-BCAAC927B1ACQ43687019-C4917185-0989-4A35-A7E1-F71D48A5399CQ43836774-358296E1-8D47-4111-86DA-681FF7E8130BQ43884348-F8D75840-5532-4E88-81E1-61EC762C8F32Q44956787-D90C26F5-40E2-4A8A-A0C8-475C16FF2651Q46404150-3FD918E0-0ED4-431A-B9BB-6F39DA169708Q46811269-BA471B86-8D4A-45AD-98BC-45ACC88CE01BQ46886246-2CF20B84-2332-4E77-98DD-4FCD82165F67Q46886256-7AF4C20B-4133-452A-9B2C-056E2A749FDDQ47725655-F008888A-1511-49F3-A374-38830138C021Q47749538-229FA908-3CA7-448F-A617-DE1BDD335959Q48097670-E2D0CFB4-76A1-4DE7-A66A-9A8B50405C3DQ48607551-C9FE4A42-38C0-4FD4-B7E8-C03F9879D275Q50125209-4984645E-CA5F-49CF-B60B-8EE357A61616Q51664361-0D0EFDA1-DD3A-4D87-A208-9BD24564F176Q51768893-F2EB18AB-9085-445F-93F6-4DC118B87902
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-1979-5769
@en
name
François Maillot
@ast
François Maillot
@en
François Maillot
@es
François Maillot
@nl
type
label
François Maillot
@ast
François Maillot
@en
François Maillot
@es
François Maillot
@nl
prefLabel
François Maillot
@ast
François Maillot
@en
François Maillot
@es
François Maillot
@nl
P106
P108
P31
P496
0000-0002-1979-5769